Event Details
January 01, 2018
Description
Level Brands acquisition of cbdMD
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| cbdMD | organization | 10 | View Entity |
| Level Brands | organization | 6 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024872.jpg
Financial Research Report / Equity Research
• 2.15 MB
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
Event Metadata
Type
Unknown
Location
U.S.
Significance Score
5/10
Participants
2
Source Documents
1
Extracted
2025-11-20 18:26
Additional Data
Source
HOUSE_OVERSIGHT_024872.jpg
Date String
2018
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event